Amphastar Pharmaceuticals Inc logo

AMPH - Amphastar Pharmaceuticals Inc News Story

$18.62 -0.2  -0.9%

Last Trade - 28/05/20

Sector
Healthcare
Size
Mid Cap
Market Cap £708.6m
Enterprise Value £730.4m
Revenue £267.1m
Position in Universe 2382nd / 6361

BRIEF-Amphastar Pharmaceuticals Q2 GAAP Earnings Per Share $0.96

Wed 7th August, 2019 9:41pm
Aug 7 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS ENDED JUNE 30, 2019
    * Q2 GAAP EARNINGS PER SHARE $0.96
    * Q2 REVENUE $79 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$77.6
MILLION
    * Q2 EARNINGS PER SHARE ESTIMATE $0.03 -- REFINITIV IBES
DATA
    * Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.08

Source text for Eikon:  ID:nGNX40K49 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.